Simple Summary Cancer treatments can cause cardiovascular toxicity, and research shows cancer survivors have an increased risk of cardiovascular disease. However, risk varies from person to person, so research efforts have focused on developing new methods to predict cancer therapy-related cardiovascular toxicity (CTR-...
C. Simela, I. Mukherjee, A. Kandala et al.· Cancers· 0 citations
Abstract Aims Cancer therapy-related cardiac dysfunction (CTRCD) is a prevalent complication with adverse clinical implications. Guidelines have emphasized the need for reliable baseline risk prediction to guide prevention strategies. While machine learning (ML) has shown promise in cardiovascular medicine, the readine...
M. Andres, Vijay Maharahan, Alexandra Pons Rivarola et al.· European Heart Journal - Dig...· 0 citations
MLTCs burden was a stronger determinant of mortality risk than CVD subtype alone, andFindings support moving beyond single-disease models towards integrated, MLTC-informed care, and pandemic preparedness.
Yogini V. Chudasama, S. Shabnam, K. Khunti et al.· Journal of public health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.